Alberto A. Castro Bigalli, MD

Join me in congratulating John Gore, MD and welcoming him into this important new leadership role! I look forward to sharing more about the division’s development and opportunities for engagement in the months ahead.

In a 14‑institution study of 2,150 cases, intraoperative 0.05% chlorhexidine gluconate use with hydrophilic inflatable penile prostheses was linked to higher infection rates (4.6% vs 2.1%) suggesting caution until further prospective data are available 🔗bit.ly/4rUU6Ag

It’s always crucial to get together outside the workplace. Thanks to @AReeseMD1 for coordinating our annual residency social event. A great night full of strikes! 🎳

Wonderful week hosting Ukrainian urologists at @CleClinicUro as we continue strengthening our collaboration to grow 🌷, innovate, and support healing in #Ukraine @GrossMedicine

Telemedicine emerged as a rare pandemic silver lining. As a specialty known for innovation, urology should continue to push policies that secure telemedicine’s future as a cornerstone for modern healthcare delivery auajournals.org/doi/abs/10.109… @AmerUrological @uretericbud @JSimhan

🎉🎊Save the Date 2/5 8pm Zoom Session🎉🎊 Jefferson Reconstructive Urology Fellowship Open House. Michael Metro and Paul Chung Co-Directors Come hear about our exciting program in Male Recon and Prosthetics. Exciting “new” fellowship with a rich history. DM for an invitation

Day 2 of our amazing trip to Ukraine .. among the boari/ reimplants/ Kulkarni and EPA we find time to connect with my amazing family ❤️ #UkraineWillPrevail

Finally made it after 36 hrs of traveling and no luggage to Lviv. Jam packed day full of urethroplasties @CleClinicUro @CaseUrology @OSU_Urology #Ukraine

Special thanks @jjmt_surgery Ethicon for their support and donation ! Leaving to 🇺🇦 Ukraine in 4 days . If you still want to support all donations are tax deductible and support our future travel gofund.me/1820deea5 through @ClevelandMaidan

I live in Charlotte. I have ridden this train with my kids. I have a few thoughts on the Murder that occurred last month on the light rail.

Philly sets the stage, Fox Chase – Temple Urologic Institute training steals the show! Urology applicants, join us on Wed! @JSimhan @AReeseMD1 @FoxChaseCancer @TempleUrology

.@JSimhan, @TempleUrology, explores the role of Paclitaxel-coated balloons, specifically Optilime, in treating #UrethralStrictures. #Functional #Urology #MensHealth

Super excited to announce the opening of our IR Center @CarolinaUrology. Hard to believe it only took 6 months from proposal to opening. Could not have done it without the hard work of @SandeepBaglaMD & team @IRcenters. Proud to offer PAE & more, in office, to our patients!

Reminder for the Temple/Fox Chase Cancer Center Urology residency program open house on Wed 9/3 from 7-8PM ET for 4th year students applying in urology. Overview of program + opportunity to ask our residents questions. Please sign up at: forms.gle/VaiBrngYrcSqGF…

IVU Mongolia 2025 is underway. Full week of urethral reconstruction planned. Thankful to Ambu for single use cystoscope donation

Congratulations!

Beautifully said.

Such a fun and exciting evening with a great talk!

If you can get it (especially in 🇺🇸), can't argue with the cost of BCG: 1 yr, $1800 👇 #EAU25 debate -- @GGiannarini making the point that BCG is still the best option for HR NMIBC @urotoday Discussing @EUplatinum paper from Scilipoti, @UroMoschini @UrogerliMD @spsutkaMD @UroDocAsh et al.

External validation of nomograms for predicting lymph node invasion (LNI) in prostate cancer patients with negative PSMA PET-CT. What did we find? The Briganti 2023 nomogram is the most accurate! 📊✅ 🔍 Why does it matter? Extended pelvic lymph node dissection (ePLND) is the gold standard for staging but comes with risks. With PSMA PET-CT revolutionizing imaging, we need better predictive tools to avoid unnecessary procedures. 📌 Key Findings: •Among 282 patients, 13% had LNI despite negative PSMA PET-CT. •The Briganti 2023 nomogram outperformed others (C-index: 77% vs. MSKCC 64%, Briganti 2017 69%, Amsterdam-Brisbane-Sydney 64%). •Using a 5% risk cutoff would spare 47% of ePLND procedures while missing only 3.8% of LNI cases! 🚫🔬 ⚖️ Clinical Impact: •Improves decision-making: More precise risk stratification means fewer unnecessary surgeries. •Saves patients from complications: ePLND has side effects; avoiding it when possible is crucial. •Guides personalized treatment: Selecting the right patients for ePLND enhances care quality. 👨‍⚕️ Takeaway: The Briganti 2023 nomogram should be the go-to tool for predicting LNI in prostate cancer patients with negative PSMA PET-CT! 📈 🔗 Read the full study here: sciencedirect.com/science/articl… #ProstateCancer #Urology #PSMAPET #LymphNodeDissection #Nomogram